Development and validation for the quantitative determination of xanthine oxidoreductase inhibitor topiroxostat by LC-MS/MS and its clinico-pharmacokinetic study

Publication date: Available online 9 July 2020Source: Journal of Pharmaceutical and Biomedical AnalysisAuthor(s): Xiangling Feng, Yan Cao, Yufeng Ding, Heng Zheng

Source: Journal of Pharmaceutical and Biomedical Analysis - July 11, 2020 Category: Drugs & Pharmacology Source Type: research